Ilyang develops new influenza antiviral drug

Published: 2010-11-23 06:56:00

Updated: 2010-11-23 06:56:00

Ilyang Pharm said it has filed a patent application for new antiviral agent, which could be used to both prevent and reduce the duration of fever and other symptoms associated with the influenza.

The mechanism of the shikimic acid-free antiviral medication is different from that of neuraminida...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK